| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000039528 |
| Receipt No. | R000045051 |
| Scientific Title | An epigenetic analysis and gene expression profiling on autoimmune gastritis; a multicenter cross-sectional and prospective study |
| Date of disclosure of the study information | 2020/03/01 |
| Last modified on | 2022/03/17 (Ver. 3) |
| Basic information | ||
| Public title | An epigenetic analysis and gene expression profiling on autoimmune gastritis; a multicenter cross-sectional and prospective study | |
| Acronym | An epigenetic analysis and gene expression profiling on autoimmune gastritis | |
| Scientific Title | An epigenetic analysis and gene expression profiling on autoimmune gastritis; a multicenter cross-sectional and prospective study | |
| Scientific Title:Acronym | An epigenetic analysis and gene expression profiling on autoimmune gastritis | |
| Region |
|
|
| Condition | ||
| Condition | autoimmune gastritis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | 1) To clarify differences in molecular morphology between AIG and HP gastritis and to clarify the mechanism through which malignant tumors develop from chronic inflammation in AIG |
| Basic objectives2 | Others |
| Basic objectives -Others | 2) To contribute to worldwide research on AIG by registering our genome-wide methylation and comprehensive gene expression information on a public database
|
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Gene expression profiling and epigenetic analysis |
| Key secondary outcomes | Statistical analysis associated with the risk of neoplasm emergence |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Case with confirmed diagnosis of AIG
2) Case with confirmed diagnosis of active HP infection 3) Case without chronic gastritis by endoscopy and inapplicable to 1),2) |
|||
| Key exclusion criteria | -Cases with medical history of H. pylori eradication treatment
-Cases with regular use of proton pomp inhibitor (PPI) / potassium-competitive acid blocker (P- CAB) -Cases with medical history of surgical operation of the upper digestive tract -Cases with medical history of malignant disease (last 5 years, with the exception of intramucosal cancer cured by local treatment) -Patients with hereditary gastrointestinal tumor diseases (familial adenomatous polyposis, Lynch syndrome, hereditary nonpolyposis colorectal cancer, Peutz-Jeghers syndrome, Cowden syndrome, hereditary diffuse gastric cancer etc.) -Cases with use of 2 or more antiplatelet drugs or anticoagulants, or with coagulation abnormalities -Cases with regular use of steroids -Minor/elderly person/handicapped person who require special consideration |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Center for Epidemiology and Preventive Medicine | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| nyamamic-tky@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Center for Epidemiology and Preventive Medicine | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| Homepage URL | |||||||
| k-niimi@umin.ac.jp | |||||||
| Sponsor | |
| Institute | Graduate School of Medicine, The University of Tokyo, Center for Epidemiology and Preventive Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Graduate School of Medicine, The University of Tokyo, Center for Epidemiology and Preventive Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Graduate School of Medicine, The University of Tokyo |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan |
| Tel | 03-3815-5411 |
| nyamamic-tky@umin.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立がん研究センター研究所・エピゲノム解析分野(東京都) National Cancer Center Research Institute, Division of Epigenomics
岡山大学バイオバンク(岡山県) Okayama University Hospital, Biobank JCHO滋賀病院・総合診療科(滋賀県) JCHO Shiga Hospital, General medical department 奈良県立医科大学・消化器/内分泌代謝内科(奈良県) Nara Medical University Hospital, Gastroenterology / Metabolism and endocrinology 浜松医科大学・臨床研究管理センター(静岡県) Hamamatsu University Hospital, Center for Clinical research 徳島県総合健診センター(徳島県) Tokushima health examination center 四谷メディカルキューブ・消化器内科(東京都) Yotsuya Medical Cube, Gastroenterology 湘南鎌倉総合病院(神奈川県) Shonan Kamakura General Hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Gene expression profiling and epigenetic analysis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045051 |